Preliminary Results on Clinicopathological and Immunohistochemical Features of Malignant Melanomas

1. Ivanisević P, Bojić L, Tomić S, et al. Clinico-epidemiological analysis of choroidal melanoma in Split Area, Croatia. Acta Med Croatica. 2011;65:257-261.Search in Google Scholar

2. Uysal IÖ, Misir M, Polat K, et al. Primary malignant melanoma of the nasal cavity. J Craniofac Surg. 2012;23:2-5.10.1097/SCS.0b013e318242057522337451Search in Google Scholar

3. Yamamura K, Kondo K, Moritani S. Primary malignant melanoma of the stomach: report of a case. Surg Today. 2012; 42:195-199.10.1007/s00595-011-0077-5326487022167480Search in Google Scholar

4. Díaz-Sánchez A, Lara MÁ, Ortega P, et al. Colorectal melanoma: review of two distinct forms of presentation. Gastroenterol Hepatol. 2011; 34:83-88.10.1016/j.gastrohep.2010.10.01221333392Search in Google Scholar

5. Ramos JA, Ramos WE, Ramos CV. Melanoma of the female urethra. Indian J Urol. 2011; 27:448-450.10.4103/0970-1591.91430326320922279307Search in Google Scholar

6. Doublali M, Chouaib A, Khallouk A, et al. Primary malignant melanoma of prostate. Urol Ann. 2010;2:76-77.10.4103/0974-7796.65105294368520882159Search in Google Scholar

7. Inoue M, Ishioka J, Kageyama Y, Fukuda H, Higashi Y. Primary malignant melanoma of the male urethra: a case report. Hinyokika Kiyo. 2008;54:305-308.Search in Google Scholar

8. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600- mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707-714.10.1056/NEJMoa1112302372451522356324Search in Google Scholar

9. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41:2040-2059.10.1016/j.ejca.2005.03.03416125929Search in Google Scholar

10. Anger M, Friedhofer H, Fukutaki MF, Ferreira MC, Landman G. Primary cutaneous melanoma: an 18-year study. Clinics (Sao Paulo). 2010;65:257-263.10.1590/S1807-59322010000300004284576520360915Search in Google Scholar

11. Döme B, Hendrix JC, Paku S et al. Biological perspectives. Alternative vascularization mechanism in cancer. Pathology and therapeutic implications. Am J Pathol 2007;170:1-15.10.2353/ajpath.2007.060302176270917200177Search in Google Scholar

12. Battisti R, Nunes DH, Weber AL, Schweitzer LC, Sgrot I. Evaluation of the epidemiological profi le and the mortality rate of the patients with primary cutaneous melanoma in Florianopolis - SC, Brazil. An Bras Dermatol. 2009;84:335-342.10.1590/S0365-0596200900040000319851664Search in Google Scholar

13. Lugowska I, Kowalska M, Zdzienicki M, et al. The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage. Pol Merkur Lekarski. 2012;32:22-27.Search in Google Scholar

14. Garbe C, Hauschild A, Volkenandt M, et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res. 2007;17:393-399.10.1097/CMR.0b013e3282f0503917992123Search in Google Scholar

15. Eggermont AM, Spatz A, Lazar V, Robert C. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity? Curr Opin Oncol. 2012;24:137-140.Search in Google Scholar

16. Kovacević P, Visnjić M, Vlajković M, Kovacević T, Visnjić A. Sentinel node biopsy for skin melanoma. Vojnosanit Pregl. 2009;66:657-662.10.2298/VSP0908657KSearch in Google Scholar

17. Ohata C, Tadokoro T, Itami S. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas. J Dermatol. 2008;35:215-221.10.1111/j.1346-8138.2008.00447.x18419678Search in Google Scholar

18. de Giorgi V, Gori A, Grazzini M, et al. Estrogens, estrogen receptors and melanoma. Expert Rev Anticancer Ther. 2011;11:739-747.10.1586/era.11.4221554049Search in Google Scholar

19. Vaisanen A, Kuvaja P, Kallioinen M, et al. A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53. Hum Pathol. 2011;42:1103-1111.10.1016/j.humpath.2010.11.01321334717Search in Google Scholar

20. Helfrich I, Schadendorf D. Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: One step forward for overcoming anti-angiogenic drug resistance? Mol Oncol. 2011;5:137-149.Search in Google Scholar

21. Mahabeleshwar GH, Byzova TV. Angiogenesis in Melanoma. Semin Oncol. 2007;34:555-565. 10.1053/j.seminoncol.2007.09.009236530618083379Search in Google Scholar